who shouldn't take glp 1 Wait Why do patients stop GLP-1

During those shortages, compounding pharmacies - which operate under federal and state compounding regulations - were permitted to prepare compounded versions of medications in shortage to help meet patient demand

When making these types of decisions, its essential to take a holistic approach to addressing these healthcare trends as an organization

Semaglutide treatment reduced body weight significantly and improved symptoms, physical limitations, and exercise function in patients across all classes of obesity

43 In a phase 3 trial including patients with obesity (excluding T2DM), the highest dose group achieved a mean weight reduction of 11.2% by week 72

Researchers should not panic if their results fall below the published averages at any given timepoint

My concern is that we dont know where that somewhere else is..yet